Mark Pykett's Email & Phone Number
Chief Executive Officer
Mark Pykett Email Addresses
Mark Pykett Phone Numbers
Mark Pykett's Work Experience
Exubrion Therapeutics
Director
January 2014 to Present
Agilis Biotherapeutics
President and CEO
January 2014 to January 2018
Health Builders
Director
January 2011 to January 2015
Navidea Biopharmaceuticals
President and CEO
January 2010 to January 2014
Alseres Pharmaceuticals
President
January 2004 to January 2010
Cytomatrix/CyGenics
CEO/President
January 1997 to January 2004
Show more
Show less
Frequently Asked Questions about Mark Pykett
What is Mark Pykett email address?
Email Mark Pykett at [email protected]. This email is the most updated Mark Pykett's email found in 2024.
How to contact Mark Pykett?
To contact Mark Pykett send an email to [email protected].
What company does Mark Pykett work for?
Mark Pykett works for Exubrion Therapeutics
What is Mark Pykett's role at Exubrion Therapeutics?
Mark Pykett is Director
What is Mark Pykett's Phone Number?
Mark Pykett's phone (413) ***-*306
What industry does Mark Pykett work in?
Mark Pykett works in the Biotechnology industry.
Mark Pykett's Professional Skills Radar Chart
Based on our findings, Mark Pykett is ...
What's on Mark Pykett's mind?
Based on our findings, Mark Pykett is ...
Mark Pykett's Estimated Salary Range
Mark Pykett Email Addresses
Mark Pykett Phone Numbers
Find emails and phone numbers for 300M professionals.
Search by name, job titles, seniority, skills, location, company name, industry, company size, revenue, and other 20+ data points to reach the right people you need. Get triple-verified contact details in one-click.In a nutshell
Mark Pykett's Ranking
Ranked #155 out of 3,104 for Director in Massachusetts
Mark Pykett's Personality Type
Extraversion (E), Intuition (N), Feeling (F), Judging (J)
Average Tenure
2 year(s), 0 month(s)
Mark Pykett's Willingness to Change Jobs
Unlikely
Likely
Open to opportunity?
There's 74% chance that Mark Pykett is seeking for new opportunities
People you may be
interested in
CEO at PTC at PTC Therapeutics, Inc.
Vice President, Head of Chemistry at PTC Therapeutics at PTC Therapeutics, Inc.
VP, Gene Therapy Research at PTC Therapeutics, Inc. at PTC Therapeutics, Inc.
Independent Board Member. VP and Chief Licensing Officer at Merck & Co., Inc. (Retired). at Symic Bio
Entrepreneur-In-Residence at Third Rock Ventures at Alnylam Pharmaceuticals
Entrepreneur In Residence, Atlas Ventures at Grünenthal Group
Managing Partner at Mission BioCapital; Chairman of Board, LabCentral at Mission BioCapital (formerly BioInnovation Capital)
Precision Medicine Pioneer and prolific inventor of ground breaking technologies to enhance medical diagnostics at DiaCarta, Inc.
Chief Scientific Officer at Orum Therapeutics at Orum Therapeutics
Chief Scientific Officer at IFM Therapeutics at Magenta Therapeutics
Founder and Chief Scientific Officer at Xeris Pharmaceuticals at Xeris Pharmaceuticals, Inc.
Bioassay Development Lead at Bill & Melinda Gates Medical Research Institute at Q² Solutions
Mark Pykett's Social Media Links
/in/mark-pykett-0171b99 /school/university-of-pennsylvania/ /redir/redirect /company/pharming